BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 7115414)

  • 1. Photoincorporation of [3H]-chloropromazine into a solubilized bovine striatal preparation.
    Thermos K; Murphy RB; Schuster DI
    Biochem Biophys Res Commun; 1982 Jun; 106(4):1469-77. PubMed ID: 7115414
    [No Abstract]   [Full Text] [Related]  

  • 2. Binding of [3H]sulpiride to purified rat striatal synaptic membranes.
    Woodruff GN; Freedman SB
    Neuroscience; 1981; 6(3):407-10. PubMed ID: 7219722
    [No Abstract]   [Full Text] [Related]  

  • 3. Similarities and dissimilarities between dopamine and neuroleptic receptors: further evidence for type 1 and type 2 dopamine receptors in the CNS.
    Spano PF; Memo M; Govoni S; Trabucchi M
    Adv Biochem Psychopharmacol; 1980; 24():113-21. PubMed ID: 6105769
    [No Abstract]   [Full Text] [Related]  

  • 4. Purification of the D-2 dopamine receptor from bovine striatum.
    Elazar Z; Kanety H; David C; Fuchs S
    Biochem Biophys Res Commun; 1988 Oct; 156(1):602-9. PubMed ID: 2972288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of an affinity chromatography matrix for the selective purification of the dopamine D2 receptor from bovine striatal membranes.
    Clagett-Dame M; Schoenleber R; Chung C; McKelvy JF
    Biochim Biophys Acta; 1989 Nov; 986(2):271-80. PubMed ID: 2531613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine denervation does not alter in vivo 3H-spiperone binding in rat striatum: implications for external imaging of dopamine receptors in Parkinson's disease.
    Bennett JP; Wooten GF
    Ann Neurol; 1986 Apr; 19(4):378-83. PubMed ID: 3707090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine/neuroleptic receptors in basal hypothalamus and pituitary.
    Brown GM; Seeman P; Lee T
    Endocrinology; 1976 Nov; 99(5):1407-6. PubMed ID: 991828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reconstitution of affinity-purified dopamine D2 receptor binding activities by specific lipids.
    Srivastava LK; Kazmi SM; Blume AJ; Mishra RK
    Biochim Biophys Acta; 1987 Jun; 900(2):175-82. PubMed ID: 2954584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are striatal [3H]spiperone radioreceptor assays indicative of multiple dopamine receptor interactions?
    Clements-Jewery S; Robson PA
    Neuropharmacology; 1981 Dec; 20(12B):1295-8. PubMed ID: 7322304
    [No Abstract]   [Full Text] [Related]  

  • 10. Preferential adsorption of dopamine antagonist binding sites by fluphenazine-agarose.
    Fong JC
    Proc Natl Sci Counc Repub China B; 1986 Apr; 10(2):113-7. PubMed ID: 3749364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative study of the relative hydrophobicity and interaction with striatal dopamine receptors in the bull of representative dialkylaminoalkyl and dialkylaminoacyl phenothiazine derivatives].
    Brusova EG; Savel'eva MV
    Biull Eksp Biol Med; 1988 Aug; 106(8):163-5. PubMed ID: 2901277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine receptor binding in the corpus striatum of mammalian brain.
    Burt DR; Enna SJ; Creese I; Snyder SH
    Proc Natl Acad Sci U S A; 1975 Nov; 72(11):4655-9. PubMed ID: 1060143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [3H]mazindol binding associated with neuronal dopamine and norepinephrine uptake sites.
    Javitch JA; Blaustein RO; Snyder SH
    Mol Pharmacol; 1984 Jul; 26(1):35-44. PubMed ID: 6087116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation by protein kinase C modulates agonist binding to striatal dopamine D2 receptors.
    Rogue P; Zwiller J; Malviya AN; Vincendon G
    Biochem Int; 1990 Nov; 22(3):575-82. PubMed ID: 1981673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe depletion of cocaine recognition sites associated with the dopamine transporter in Parkinson's-diseased striatum.
    Kaufman MJ; Madras BK
    Synapse; 1991 Sep; 9(1):43-9. PubMed ID: 1796351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [3H]GBR-12935 binding to dopamine uptake sites in rat striatum.
    Allard PO; Eriksson K; Ross SB; Marcusson JO
    Neuropsychobiology; 1990-1991; 23(4):177-81. PubMed ID: 2130286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor binding potencies of chlorpromazine, trifluoperazine, fluphenazine and their 10-N-substituted analogues.
    Savelyeva MV; Baldenkov GN; Kaverina NV
    Biomed Biochim Acta; 1988; 47(12):1085-7. PubMed ID: 2855395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [3H]Ro 22-1319 (piquindone) binds to the D2 dopaminergic receptor subtype in a sodium-dependent manner.
    Nakajima T; Iwata K
    Mol Pharmacol; 1984 Nov; 26(3):430-8. PubMed ID: 6149457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photoaffinity labeling of D-2 dopamine binding subunits from rat striatum, anterior pituitary and olfactory bulb with a new probe, [3H]azidosulpride.
    Redouane K; Sokoloff P; Schwartz JC; Hamdi P; Mann A; Wermuth CG; Roy J; Morgat JL
    Biochem Biophys Res Commun; 1985 Aug; 130(3):1086-92. PubMed ID: 3161508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photoaffinity labeling of the dopamine reuptake carrier protein with 3-azido[3H]GBR-12935.
    Berger SP; Martenson RE; Laing P; Thurkauf A; Decosta B; Rice KC; Paul SM
    Mol Pharmacol; 1991 Apr; 39(4):429-35. PubMed ID: 2017146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.